Amarin sues AstraZeneca ahead of launch of Vascepa competitor | PharmaBoardroom
written on 05.03.2014
Tags:
,

Amarin sues AstraZeneca ahead of launch of Vascepa competitor

TAGS: ,

Amarin's lawyers were just in court last week suing the FDA for limiting the exclusivity it granted the drugmaker's fish oil pill Vascepa. But the Irish drugmaker hustled them back to court Tuesday, this time to sue AzstraZeneca, which is awaiting FDA approval on its own product for treating super-high cholesterol.

Latest Report